2022 annual financial data
Xenetic Biosciences 2022 Operating margin
Direct answer
Operating margin was -393.57%.
Operating income was -6,717,908 USD and net income was -6,552,353 USD.
Operating cash flow was -4,646,765 USD.
Get free Xenetic Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,706,925 USD
- Operating income
- -6,717,908 USD
- Net income
- -6,552,353 USD
- Operating cash flow
- -4,646,765 USD